E-LIB Suche - Ergebnisse für: Wilhelm-Benartzi, Charlotte

1

P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH..:

Russell, Nigel ; Cumming, Oliver ; Othman, Jad...
HemaSphere. 7 (2023) S3 - p. e13145db , 2023

Link: https://doi.org/10.1097/..

2

A randomized comparison of CPX-351 and FLAG-Ida in adverse ..:

Othman, Jad ; Wilhelm-Benartzi, Charlotte ; Dillon, Richard...
Blood Advances. 7 (2023) 16 - p. 4539-4549 , 2023

Link: https://doi.org/10.1182/..

3

P503: A RANDOMISED TRIAL OF MOLECULAR MONITORING VERSUS STA..:

Potter, Nicola ; Jovanovic, Jelena ; Ivey, Adam...
HemaSphere. 7 (2023) S3 - p. e345570d , 2023

Link: https://doi.org/10.1097/..

4

S134: FLAG-IDA COMBINED WITH GEMTUZUMAB OZOGAMICIN (GO) RED..:

Russell, Nigel ; Othman, Jad ; Dillon, Richard...
HemaSphere. 7 (2023) S3 - p. e252478c , 2023

Link: https://doi.org/10.1097/..

5

Serum Flt3 ligand is a biomarker of progenitor cell mass an..:

Milne, Paul ; Wilhelm-Benartzi, Charlotte ; Grunwald, Michael R....
Blood Advances. 3 (2019) 20 - p. 3052-3061 , 2019

Link: https://doi.org/10.1182/..

6

Prediction of mode of delivery using the first ultrasound-b..:

Usman, Sana ; Kahrs, Birgitte Heiberg ; Wilhelm-Benartzi, Charlotte...
American Journal of Obstetrics and Gynecology. 221 (2019) 2 - p. 163-166 , 2019

Link: https://doi.org/10.1016/..

7

A model to predict vaginal delivery in nulliparous women ba..:

Eggebø, Tørbjorn Moe ; Wilhelm-Benartzi, Charlotte ; Hassan, Wassim A....
American Journal of Obstetrics and Gynecology. 213 (2015) 3 - p. 362.e1-362.e6 , 2015

Link: https://doi.org/10.1016/..

8

Erratum: Corrigendum: Whole–genome characterization of chem..:

The Australian Ovarian Cancer Study ; Patch, Ann-Marie ; Christie, Elizabeth L....
Nature. 527 (2015) 7578 - p. 398-398 , 2015

Link: https://doi.org/10.1038/..

9

Whole–genome characterization of chemoresistant ovarian can..:

Patch, Ann-Marie ; Christie, Elizabeth L. ; Etemadmoghadam, Dariush...
Nature. 521 (2015) 7553 - p. 489-494 , 2015

Link: https://doi.org/10.1038/..

10

Birthweight is associated with DNA promoter methylation of ..:

Filiberto, Amanda C. ; Maccani, Matthew A. ; Koestler, Devin C....
Epigenetics. 6 (2011) 5 - p. 566-572 , 2011

Link: https://doi.org/10.4161/..

11

Study protocol: Minimum effective low dose: anti-human thym..:

Wilhelm-Benartzi, Charlotte S ; Miller, Sarah E ; Bruggraber, Sylvaine...
BMJ Open. 11 (2021) 12 - p. e053669 , 2021

Link: https://doi.org/10.1136/..

12

Circulating biomarkers and outcomes from a randomised phase..:

Willenbrock, Frances ; Cox, Catrin M. ; Parkes, Eileen E....
British Journal of Cancer. 124 (2020) 3 - p. 581-586 , 2020

Link: https://doi.org/10.1038/..

13

NY-ESO-1 expression in DCIS: A new predictor of good progno..:

Coombes, R. Charles ; Caballero, Otavia L. ; Shousha, Sami...
Oncoscience. 4 (2017) 3-4 - p. 33-40 , 2017

Link: https://doi.org/10.18632..

14

Challenges and methodology in the incorporation of biomarke..:

Wilhelm-Benartzi, Charlotte S. ; Mt-Isa, Shahrul ; Fiorentino, Francesca..
Critical Reviews in Oncology/Hematology. 110 (2017) - p. 49-61 , 2017

Link: https://doi.org/10.1016/..

15

Methylation of MYLK3 gene promoter region: a biomarker to s..:

Phelps, David L ; Borley, Jane V ; Flower, Kirsty J...
British Journal of Cancer. 116 (2017) 10 - p. 1287-1293 , 2017

Link: https://doi.org/10.1038/..